|1.||Schmid-Hempel, Paul: 1 article (12/2013)|
|2.||Barribeau, Seth M: 1 article (12/2013)|
|3.||Welling, Mick M: 1 article (09/2011)|
|4.||Brouwer, Carlo P J M: 1 article (09/2011)|
|5.||Rahman, Mahfuzur: 1 article (09/2011)|
|6.||Smit, Nienke: 1 article (01/2011)|
|7.||Martínez-Barnetche, Jesús: 1 article (01/2011)|
|8.||Lanz-Mendoza, Humberto: 1 article (01/2011)|
|9.||Rodriguez, Mario H: 1 article (01/2011)|
|10.||Herrera-Ortiz, Antonia: 1 article (01/2011)|
12/01/2013 - "Interestingly, infection with one clone results in up regulation of AMP's similar to bees given the bacterial challenge, while genes related to metabolism, signalling, and other effectors were similar between the two Crithidia exposures. "
09/01/2011 - "Another approach of using AMP's is their use in prevention of infections e.g. "
09/01/2011 - "Their unique mechanism of action and safety profile makes AMP's appealing candidates for simultaneous or sequential use in different cases of infections. "
01/01/2011 - "berghei infection on the AMP's expression, and exogenous NO and H(2)O(2) induced their expression in the mosquito fat body. "
|2.||Chronic Obstructive Pulmonary Disease (COPD)
|3.||Asthma (Bronchial Asthma)